|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 113.45 EUR | +0.49% |
|
+2.71% | -7.38% |
| 05-11 | Weekly Earnings Calendar | |
| 05-07 | Genetix Selects Merck KGaA as Sole Testing Provider for Gene Therapies | MT |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 19.08x | 1.62x | -13.8x | 2.69x | 9.9x | 15.8x | 2.07% | 57.84B | ||
| 15.27x | 1.34x | 0.7x | 1.94x | 6.93x | 8.61x | 2.87% | 7.95B | ||
| 9.52x | 8.32x | 0.06x | 5.07x | 7.76x | 8.4x | - | 7.87B | ||
| 28.28x | 6.89x | 12.46x | 7.63x | 21.21x | 21.92x | -.--% | 5.26B | ||
| 45.55x | 2.8x | -1.6x | 2.66x | 32.39x | 46.47x | 0.65% | 4.28B | ||
| 28.52x | - | 0.18x | 5.46x | 15.6x | 25.28x | - | 3.3B | ||
| 113.93x | - | -0.7x | - | - | - | -.--% | 2.87B | ||
| 56.72x | 8.89x | -1.47x | 19.52x | 41x | 48.23x | - | 1.24B | ||
| -8.26x | 15.49x | 1.14x | 289.4x | -6.78x | -5.66x | -.--% | 1.22B | ||
| 14.25x | 0.95x | 1.01x | 1.36x | 34.06x | -92.79x | 3.59% | 1.18B | ||
| -86.64x | 2.1x | 1.3x | - | - | - | - | 1.16B | ||
| 32.8x | 1.19x | 0.64x | 1.98x | 17.51x | 25.8x | - | 939M | ||
| Average | 22.42x | 4.96x | -0.01x | 33.77x | 17.96x | 10.21x | 1.31% | 7.92B | |
| Weighted average by Cap. | 21.78x | 2.84x | -7.70x | 7.25x | 11.97x | 15.53x | 1.85% |
- Stock Market
- Equities
- MRK Stock
- Sector Merck KGaA
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















